关注
Kartik Mitra
Kartik Mitra
Researcher, Indian Institute of Technology - Madras
在 nus.edu.sg 的电子邮件经过验证
标题
引用次数
引用次数
年份
Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo
NS Sundaramoorthy, K Mitra, JS Ganesh, H Makala, R Lotha, ...
Microbial pathogenesis 124, 54-62, 2018
362018
Dual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads
K Mitra, P Ghanta, S Acharya, G Chakrapani, B Ramaiah, M Doble
Journal of Biomolecular Structure and Dynamics 39 (16), 6324-6337, 2021
302021
Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein
R Manjunathan, V Periyaswami, K Mitra, AS Rosita, M Pandya, J Selvaraj, ...
BMC bioinformatics 23 (1), 180, 2022
282022
Pharmacophore based approach to screen and evaluate novel Mycobacterium cell division inhibitors targeting FtsZ–A modelling and experimental study
K Mitra, A Chadha, M Doble
European Journal of Pharmaceutical Sciences 135, 103-112, 2019
182019
Preparation of Curdlan sulphate-Chitosan nanoparticles as a drug carrier to target Mycobacterium smegmatis infected macrophages
R Ravindran, K Mitra, SK Arumugam, M Doble
Carbohydrate Polymers 258, 117686, 2021
172021
Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)—A cell division protein
R Ravindran, G Chakrapani, K Mitra, M Doble
PloS one 15 (5), e0232482, 2020
172020
Self-assembled inhalable immunomodulatory silk fibroin nanocarriers for enhanced drug loading and intracellular antibacterial activity
K Mitra, A Chadha, V Muthuvijayan, M Doble
ACS Biomaterials Science & Engineering 8 (2), 708-721, 2022
112022
Liver cancer in 2021: Global burden of disease study
EY Tan, P Danpanichkul, JN Yong, Z Yu, DJH Tan, WH Lim, B Koh, ...
Journal of Hepatology, 2024
62024
Arjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies
GS Arumugam, A Sen, SS Dash, K Mitra, M Doble, G Rajaraman, ...
Journal of Biomolecular Structure and Dynamics 40 (22), 12358-12379, 2022
62022
Synthesis of novel spirobibenzopyrans as potent anticancer leads inducing apoptosis in HeLa cells
S Kar, G Ramamoorthy, K Mitra, N Shivalingegowda, SK Mavileti, ...
Bioorganic & Medicinal Chemistry Letters 30 (12), 127199, 2020
62020
Characteristics of contemporary drug clinical trials regarding the treatment of non-alcoholic steatohepatitis
S Zhao, L Zhang, J Zhao, VG Kota, KM Venkat, F Tasnim, H Yu
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 18 (1), 102921, 2024
32024
Disrupting Mycobacterium smegmatis biofilm using enzyme-immobilized rifampicin loaded silk fibroin nanoparticles for dual anti-bacterial and anti-biofilm action
V Gopinath, K Mitra, A Chadha, M Doble
Microbial Pathogenesis 196, 106999, 2024
22024
High molecular weight heparin-induced angiogenesis mainly mediated via basic fibroblast growth factor-2-an in-vivo (CAM) and in-silico analysis
R Manjunathan, K Mitra, R Vasvani, M Doble
Biochemistry and Biophysics Reports 37, 101609, 2024
12024
A network pharmacology-based approach to understand the mechanism of action of anti-mycobacterial activity of Acacia nilotica: a modelling and experimental study
M Suresh, KV Sai, K Mitra, R Ravindran, M Doble
Molecular Diversity, 1-16, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–14